Assays for Pharmaceutical Industry and Biotechnology companies

Mitologics intervenes at different levels of drug discovery & development:

• Healthcare assessment by toxicity assays on isolated mitochondria and healthy cells. Potential mitochondrial toxicity can be controlled at each stage of drug discovery, in high or medium throughput.

• Identification of mitochondria as an off-target for drugs presenting signs of organo-toxicity during clinical phases.

• Assays on healthy versus tumor mitochondria.

• Validation of compounds protective effect during drug discovery.